Showing results (421-430 of 2,509) with videos related to
Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|October 15, 2021
FMS-Like Tyrosine Kinase 3 Inhibitors for the Treatment of Acute Myeloid LeukemiaElli D Novatcheva, Yasmine Anouty, Ila Saunders, et al.Clinical Lymphoma, Myeloma & Leukemia|March 9, 2022
A Phase 1/2 Study of the Oral Janus Kinase 1 Inhibitors INCB052793 and Itacitinib Alone or in Combination With Standard Therapies for Advanced Hematologic MalignanciesAmer M Zeidan, Rachel J Cook, Rodolfo Bordoni, et al.Clinical Lymphoma, Myeloma & Leukemia|March 16, 2022
The Importance of FISH Signal Cut-off Value and Copy Number Variation for 1q21 in Newly Diagnosed Multiple Myeloma: Is it Underestimated?Lu Gao, Yang Liu, Ye Li, et al.Clinical Lymphoma, Myeloma & Leukemia|October 8, 2018
Health-Related Quality of Life of Patients With Multiple Myeloma Treated in Routine Clinical Practice in FranceNicolas Despiégel, Chantal Touboul, Alain Flinois, et al.Clinical Lymphoma, Myeloma & Leukemia|October 8, 2018
Interim Functional Imaging Is an Independent Predictor of Progression-free Survival in Advanced Classical Hodgkin Lymphoma - A Real-world AnalysisMoussab Damlaj, Mohsen Al-Zahrani, Ghulam Syed, et al.Clinical Lymphoma, Myeloma & Leukemia|October 10, 2018
Analysis of Availability and Access of Anti-myeloma Drugs and Impact on the Management of Multiple Myeloma in Latin American CountriesRoberto José Pessoa de Magalhães Filho, Edvan Crusoe, Eloisa Riva, et al.Clinical Lymphoma, Myeloma & Leukemia|May 8, 2019
Favorable Outcomes With Tumor Burden Reduction Following Administration of Hypomethylating Agents Before Allogeneic Hematopoietic Cell Transplantation in Patients With Higher Risk Myelodysplastic SyndromeSungwoo Park, Dong Won Baek, Sang Kyun Sohn, et al.Clinical Lymphoma, Myeloma & Leukemia|June 30, 2019
High-dose Therapy and Autologous Hematopoietic Cell Transplantation as Consolidation Treatment for Primary Effusion LymphomaAbu-Sayeef Mirza, Bhagirathbhai R Dholaria, Mohammad Hussaini, et al.Clinical Lymphoma, Myeloma & Leukemia|April 25, 2018
Circulating Soluble Receptor Activator of Nuclear Factor Kappa B Ligand and C-C Motif Ligand 3 Correlate With Survival in Patients With Waldenström MacroglobulinemiaEvangelos Eleutherakis-Papaiakovou, Efstathios Kastritis, Maria Gavriatopoulou, et al.Clinical Lymphoma, Myeloma & Leukemia|April 15, 2023
SOHO State-of-the-Art Updates and Next Questions: A Modern Approach to the Systemic Treatment of Advanced CTCLDanielle Brazel, Lauren Pinter-BrownPageof 251